BCG: myths, realities, and the need for alternative vaccine strategies.
about
Vaccine development for tuberculosis: current progressTuberculosis vaccine types and timingsAttrition of T-cell functions and simultaneous upregulation of inhibitory markers correspond with the waning of BCG-induced protection against tuberculosis in mice.The DosR Regulon Modulates Adaptive Immunity and Is Essential for Mycobacterium tuberculosis Persistence.Nonclinical Development of BCG Replacement Vaccine Candidates.The Functional Response of B Cells to Antigenic Stimulation: A Preliminary Report of Latent Tuberculosis.Mucosal vaccination with attenuated Mycobacterium tuberculosis induces strong central memory responses and protects against tuberculosisMixed-strain mycobacterium tuberculosis infections and the implications for tuberculosis treatment and controlCharacterization of W-Beijing isolates of Mycobacterium tuberculosis from the Western Cape.The effectiveness of BCG vaccination in preventing Mycobacterium tuberculosis infection and disease in Greenland.High mobility group box 1 acts as an adjuvant for tuberculosis subunit vaccines.BCG Vaccination Induces Robust CD4+ T Cell Responses to Mycobacterium tuberculosis Complex-Specific Lipopeptides in Guinea Pigs.Novel chimpanzee adenovirus-vectored respiratory mucosal tuberculosis vaccine: overcoming local anti-human adenovirus immunity for potent TB protection.Non-pathological infection of macaques by an attenuated mycobacterial vaccine is not reactivated in the setting of HIV coinfection.Trying to See the Forest through the Trees: Deciphering the Nature of Memory Immunity to Mycobacterium tuberculosis.Vaccines for Leprosy and Tuberculosis: Opportunities for Shared Research, Development, and Application.Age-related waning of immune responses to BCG in healthy children supports the need for a booster dose of BCG in TB endemic countries
P2860
Q26827737-12BF26B8-EEB0-44F4-AC36-D171F4783D4CQ26862762-BB2531F6-E4EF-4BB4-8CB1-90A8AFCB0ACFQ34566311-D53D2C26-B6DF-46A9-ACF5-814D3EB571C9Q35672595-01F6DB10-7100-4D2C-A75A-7AB89DAD7208Q35890636-520B90B5-F1C9-4365-AA21-3A5C2FA5250DQ35981017-106A5243-8C93-4EE2-BD77-D3D321512589Q36169358-D935A6A6-BC11-41FA-9989-983AD11CC602Q36361918-1DF4BE65-C64B-45D7-967E-644918795764Q37455406-6E95EA98-6548-4C89-9E88-3220D1806A41Q38427700-A3BA96E6-69B0-46FB-919F-39DB6986CF09Q39042197-04BD214F-1EE1-4F16-A336-C94F69FBB5E6Q40786879-66BD79A7-1F61-4713-B1EA-4078074C19B8Q41335764-911DFF9F-0919-41CD-8A0E-F26B49FDCC33Q41932554-600D0E0F-C005-4050-8D7D-E38E85E41F94Q52641618-3ABC4618-9F9F-4875-9DBA-BDB7CFF1986BQ52657152-652F5D91-8723-4FC8-9E5B-E7C2F16FF077Q58549133-A1D924CA-2BA3-4E43-BAD8-3943CDD16482
P2860
BCG: myths, realities, and the need for alternative vaccine strategies.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
BCG: myths, realities, and the need for alternative vaccine strategies.
@en
type
label
BCG: myths, realities, and the need for alternative vaccine strategies.
@en
prefLabel
BCG: myths, realities, and the need for alternative vaccine strategies.
@en
P2093
P1433
P1476
BCG: myths, realities, and the need for alternative vaccine strategies.
@en
P2093
Ann Williams
David N McMurray
Ian M Orme
Marcel Behr
Paul E Fine
William R Jacobs
P304
P356
10.1016/J.TUBE.2011.12.003
P577
2012-02-18T00:00:00Z